Literature DB >> 15691300

Effects of lactulose and polyethylene glycol on colonic transit.

E Fritz1, H F Hammer, R W Lipp, C Högenauer, R Stauber, J Hammer.   

Abstract

BACKGROUND: The effects of lactulose and polyethylene glycol on colonic transit are poorly established. AIM: To assess the effects of these laxatives on colonic transit in normal subjects.
METHODS: Colonic transit (mean residence time, cumulative counts in stool, counts remaining in the proximal or distal colon) was measured scintigraphically in normal subjects on the second and third day of a 3-day ingestion of 67-134 g/day lactulose, or 59 g/day polyethylene glycol.
RESULTS: At similar stool weight (lactulose: 653 +/- 120 g/day; polyethylene glycol: 522 +/- 66 g/day), transit was significantly slower during 99 g/day lactulose when compared with 59 g/day polyethylene glycol; this was most pronounced in the distal colon (mean residence time: lactulose - 403 +/- 55 min; polyethylene glycol - 160 +/- 41.9 min). Short chain fatty acid concentration in 24-h stool correlated significantly with counts remaining in the distal colon at 12 h (r = 0.79, P = 0.001). Increasing lactulose doses were significantly associated with increasing stool weight (r = 0.79) and shorter mean residence time in the total (r = -0.56) and distal colon (r = -0.64). The sum of faecal carbohydrates plus short chain fatty acids was associated with stool weight (r = 0.95, P < 0.001).
CONCLUSION: Lactulose accelerates colonic transit. However, compared with polyethylene glycol, transit during lactulose is prolonged.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691300     DOI: 10.1111/j.1365-2036.2005.02244.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  12 in total

1.  Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial.

Authors:  S N Sgouros; J Vlachogiannakos; K Vassiliadis; C Bergele; G Stefanidis; H Nastos; A Avgerinos; A Mantides
Journal:  Gut       Date:  2005-11-23       Impact factor: 23.059

2.  Cirrhotic Patients Have Worse Bowel Preparation at Screening Colonoscopy than Chronic Liver Disease Patients without Cirrhosis.

Authors:  Anika K Anam; Kunal Karia; Arun B Jesudian; Brian P Bosworth
Journal:  J Clin Exp Hepatol       Date:  2016-08-31

Review 3.  Defecation disorders: neuromuscular aspects and treatment.

Authors:  Jose M Remes-Troche; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2006-08

4.  6β-N-heterocyclic substituted naltrexamine derivative NAP as a potential lead to develop peripheral mu opioid receptor selective antagonists.

Authors:  Yunyun Yuan; David L Stevens; Amanda Braithwaite; Krista L Scoggins; Edward J Bilsky; Hamid I Akbarali; William L Dewey; Yan Zhang
Journal:  Bioorg Med Chem Lett       Date:  2012-05-26       Impact factor: 2.823

5.  Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrence.

Authors:  Steven L Flamm
Journal:  Therap Adv Gastroenterol       Date:  2011-05       Impact factor: 4.409

Review 6.  Treating chronic constipation : How should we interpret the recommendations?

Authors:  David A Johnson
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

7.  Efficacy and tolerability of Laxatan Granulat in patients with chronic constipation.

Authors:  Joerg Gruenwald; Regina Busch; Christine Bentley
Journal:  Clin Exp Gastroenterol       Date:  2009-09-04

Review 8.  Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?

Authors:  Mirjana Rajilić-Stojanović; Daisy M Jonkers; Anne Salonen; Kurt Hanevik; Jeroen Raes; Jonna Jalanka; Willem M de Vos; Chaysavanh Manichanh; Natasa Golic; Paul Enck; Elena Philippou; Fuad A Iraqi; Gerard Clarke; Robin C Spiller; John Penders
Journal:  Am J Gastroenterol       Date:  2015-01-27       Impact factor: 10.864

9.  Effect and safety of deep needling and shallow needling for functional constipation: a multicenter, randomized controlled trial.

Authors:  Jiani Wu; Baoyan Liu; Ning Li; Jianhua Sun; Lingling Wang; Liping Wang; Yuying Cai; Yongming Ye; Jun Liu; Yang Wang; Zhishun Liu
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

10.  Longer colonic transit time is associated with laxative and drug use, lifestyle factors, and symptoms of constipation.

Authors:  Johan Bohlin; Erik Dahlin; Julia Dreja; Bodil Roth; Olle Ekberg; Bodil Ohlsson
Journal:  Acta Radiol Open       Date:  2018-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.